De-intensified chemoradiotherapy clinical trials

p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)

This study looks at a new way to give radiation and chemotherapy for a type of throat cancer called p16+ oropharyngeal cancer. It aims to reduce side effects by lowering radiation doses to healthy areas while still fighting the cancer effectively.